Serum immunogloblins might be useful predictors of immune‐related adverse events after immune checkpoint inhibitor usage in lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum immunogloblins might be useful predictors of immune‐related adverse events after immune checkpoint inhibitor usage in lung cancer

Published:2022-07-22 Issue:17 Volume:13 Page:2536-2538
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Yasuda Manabu¹^ORCID,Take Nobuyuki¹,Shinohara Shinji¹,Chikaishi Yasuhiro¹

Affiliation:

1. Department of Chest Surgery Iizuka Hospital Fukuoka Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14573

Reference10 articles.

1. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

2. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

3. Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors

4. Tumor‐infiltrating B lymphocytes as a potential source of identifying tumor antigen in human lung cancer;Yasuda M;Cancer Res,2002

5. Simultaneous Cellular and Humoral Immune Response against Mutated p53 in a Patient with Lung Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined with prognostic nutritional index and IgM for predicting the clinical outcomes of gastric cancer patients who received surgery;Frontiers in Oncology;2023-06-09

2. Pembrolizumab;Reactions Weekly;2022-10-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP